Иммунофенотипическая дифференцировка лейкозов и лимфом: лабораторная диагностика и мониторинг
Диссертация
Иммунофенотипирование (ИФТ) приобретает все большую значимость в ведении онкогематологических больных, так как позволяет быстро получать информацию, имеющую безусловную ценность для диагностики лейкозов и лимфом, для определения группы риска и тактики лечения с использованием новых протоколов, включая такие высокотехнологичные, как трансплантация гемопоэтических стволовых клеток (ТГСК). Время… Читать ещё >
Список литературы
- Абелев Г. И. Что такое опухоль? // Соросовский Образовательный Журнал. 1997. № 4. — С. 17−22.
- Барышников А.Ю., Кадагидзе З. Г., Малахова JI.A., Тупицын H.H. Иммунологический фенотип лейкозной клетки. М.: Медицина, 1989.-240с.
- Ван Донген Ж., Никитин В. Ю. Проточная цитометрия в диагностике хронических лимфопролиферативных заболеваний / материалы Российско-Голландской конференции «Диагностика и лечение лимфом». 2002. — С.7−33.
- Думпе Э.П., Ухов Ю. И., Швальб П. Г. Физиология и патология венозного кровообращения нижних конечностей. М.: Медицина, 1982.-167с.
- Ин-т проблем онкологии им Р. Е. Кавецкого. Киев.: Наук. Думка, 1990.-232с.
- Исхаков А., Алексеев JL, Бачурин П., Яздовский В. Комплементзависмый микролимфоцитотоксический тест для количественного анализа субпопуляций лимфоцитов // Иммунология. -1988. № 6. С.75−76.
- Клиническая онкогематология: Руководство для врачей. Под ред. М. А. Волковой. М.: Медицина, 2001. — 576 с.
- Лецкий В.Б. Цитохимические исследования лейкоцитов (методическое письмо).- Л.-1970.- 32 стр.
- Луговская С.А., Морозова В. Т., Почтарь М. Е. Лабораторная диагностика острых лейкозов. Тверь: Губернская медицина. — 1999. -80с.
- Медицинская лабораторная диагностика (программы и алгоритмы). Справочник / под ред. проф. А. И. Карпищенко, СПб, Интермедика, 2001, 544 стр. с илл.
- Методы проточной цитометрии в медицинских и биологических исследованиях / под ред. М. Потапнева. Минск: ГУРНМБ, 2003, -136с.
- Молекулярная клиническая диагностика. Методы. / Под ред. С. Херрингтона, Дж. Макги. М. -Мир. — 1999. — 557с.
- Новик A.A. Классификация злокачественных лимфом. СПб: ЭЛБИ.-2000.-126с.
- Новик A.A., Богданов А. Н. Принципы трансплантации костного мозга и стволовых кроветворных клеток периферической крови. -СПб.:ВМедА, 2001. 168с.
- Полак Дж., Ван Норден С. Введение в иммуноцитохимию: современные методы и проблемы. М.:Мир. -1987. 70с.
- Разнатовский И.М., Ястребов В. В. Лимфомы кожи. / С-Петербург. -НеваПресс. 1997. — 55с.
- Ройт А., Бростофф Дж., Мейл Д. Иммунология. 2000 г. М. Мир, 580с.
- Рукавицын А.О. Роль иммунотерапии в лечении больных заболеваниями системы крови // Вопросы онкологии. 2002. — № 2. -С.186−192.
- Руководство по гематологии в 3 т. Т.1. / Под ред. А. И. Воробьева. -М.: Ньюдиамед, 2002, 280с.
- Савельев B.C. Современные направления в хирургическом лечении хронической венозной недостаточности // Флеболимфология. 1996. -№ 1. — С.5−7.
- Савченко В.Г., Паровичников E.H. Лечение острых лейкозов (клинические исследования). М.:МЕДпресс-информ, 2004.- 224с.
- Серебряная Н.Б. Иммунопатогенез B-клеточных лимфом // Медицинская иммунология. 2002. — Т.4. № 4−5. — С.53 5−544.
- Стрижаков А.Н., Мхеидзе Д. М., Тимохина Е. В., Гришина В. В. Пуповинная кровь источник стволовых клеток // Вопросы гинекологии, акушерства и перинатологии. -2003.-Т.2. № 4.-C.33−37.
- Тотолян А.А., Фрейдлин И. С. Клетки иммунной системы. СПб.: Наука. — 2000.- Т.1-Т.2. 231с.
- Управление качеством клинических лабораторных исследований. Нормативные документы. Под ред В. В. Меньшикова. М: Лабпресс. -2000.-152с.
- Фатех-Могхадам А., П. Стиебер Рациональное использование опухолевых маркеров. 1993. — 70с.
- Хаитов P.M., Вербицкий М. Ш. Онтогенез иммунной системы // Итоги науки и техники ВИНИТИ. Сер. Иммунология.- 1986. Т. 14. -165с.
- Чередеев А.Н., Горлина Н. А., Козлов И.Г. CD-маркеры в практике клинико-диагностических лабораторий // Клин, лабор. диагн. 1999. — № 6. — С.25−32.
- Эллиниди В.Н., Аникеева Н. В., Максимова Н. А. Практическая иммуногистоцитохимия (Методические рекомендации) СПб.: ВЦЭРМ МЧС России, 2002. — 36с.
- Яблоков Е.Г., Кириенко А. И., Богачев В. Ю. Хроническая венозная недостаточность. М.: Медицина. — 1999. — 218с.
- Allman R. Flow cytometry: principles and application. In: Clinical Flow cytometry. Principles and application. Ed. by Bauer K.D., Duque R.E., Shankey T.V. / Proceedings RMS. 1993. — Vol.28. № 2. — P.45−54.
- Avrameas S. and Uriel J. Method of antigen and antibody labeling with enzymes and its immunodiffusion application. // C. R. Acad. Sci. Paris. -1966. Vol.262. № 24. -P.2543−2545. French.
- Avrameas S. Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies // Immunochemistry. 1969. — Vol.6. № 1. — P.43−52.
- Bain B.J. Routine and specialized techniques in the diagnosis of haematological neoplasms // J. Clin. Pathol. 1995. — Vol.48. № 6. — P.501−508.
- Bakker S.T.C., De Grooth B.G., Greve J. Cluster analysis of flow cytometric list mode data on a personal computer // Cytometry. 1993. -Vol.14.-P.649−659.
- Banker D.E., Groudine M., Willman C.L., Norwood T., Appelbaum F.R. Measurements of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia // Blood. 1997. -Vol.89. — P.243−255.
- Basso G., Buldidni B., de Zen L., Orfao A. New immunologic approaches for imunophenotyping acute leukemias // Hematologica. 2001. -Vol.86. № 7.-P.675−692.
- Basso G., Rondelli R., Covezzoli A., Putti M. The role of immunophenotype in acute lymphoblastic leukemia of infant age // Leuk. Lymphoma. 1994. — Vol.15. № 1−2. — P.51−60.
- Beljaards R.C., Meijer C.J., Scheffer E., van Vloten W.A., Willemze R. Cutaneous large cell lymphomas of T cell origin: diagnosis, classification and prognostic parameters // Curr. Probl. Dermatol. 1990. — Vol.19. -P.144−149.
- Belov L., de la Vega O., dos Remedios C.G., Mulligan S.P., Christopherson R.L., Immunophenotyping of leukemias using a cluster of differentiation antibody microarray // Cancer Res. 2001. — Vol.61. № 11.-P.4483−4489.
- Bene M.C., Bernier M., Castoldi G., Faure G.C., Knap W., Ludwig W.D., Matute E., Orfao A., van der Veer M. Impact of Immunophenotyping on management of acute leukemias // Hematologica. 1999. — Vol.84. -P.1024−1034.
- Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group // Br. J. Haematol. 1976. — Vol.33. № 4. — P.451−458.
- Binet J.L., Auquier A., Dighiero G. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis // Cancer. 1981. — Vol.48. — P.198−206.
- Borella L., Casper J.T., Lauer S.J. Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse // Blood. 1979. — Vol.54. № 1.-P.64−71.
- Borowitz M., Shuster J., Carroll A. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study // Blood. -1997. Vol.89. — P.3960−3966.
- Bosse R, Kulmburg P, von Kalle C, Engelhardt M, Dwenger A, Rosenthal F, Schulz G. Production of stem-cell transplants according to good manufacturing practice // Ann Hematol. 2000. — Vol.79. № 9. -P.469−476.
- Boyum A. Separation of leukocytes from blood and bone marrow // Scand. J. Clin. Lab. Invest. -1968. Vol.21. Suppl.97. — P. l-9.
- Brandtzaeg P., Halstensen T.S., Huitfeldt H.S., Valnes K.N. Immunofluorescence and immunoenzyme histochemistry. In: Johnstone AP, Turner MW, eds. Immunochemistry 2. A Practical Approach. Oxford University Press: Oxford. 1997. — P.71−130.
- Braylan R.C., Orfao A., Borowitz M.J., Davis B.H. Optimal number of reagents required to evaluate hematolymphoid neoplasias: result of an international consensus meeting // Cytometry. 2001. — Vol.46. № 16. -P.23−27.
- Burke M.D. Clinical laboratory consultation // Clin. Chem. 1995. -Vol.41.-P.1237−1240.
- Busachi C.A., Ray M.B., Desmet V.J. An immunoperoxidase technique for demonstrating membrane localized HBsAg in paraffin sections of liver biopsies // J. Histochem. Cytochem. 1978. — Vol.19. — P.95−99.
- Caligaris-Capio F. How immunology is reshaping clinical disciplines: the example of hematology // Lancet. 2001. — Vol.358. № 9275. — P.49−55.
- Callam M.J. Epidemiology of varicose veins // Br. J. Surg.- 1994. -Vol.81. P.1671−1673.
- Campana D., Coustan-Smith E. Minimal residual disease studies by flow cytometry in acute leukemia // Acta Haematol. 2004. — Vol.112. № 1−2. -P.8−15.
- Campana D., Behm F.G. Immunophenotyping of leukemia // J. Imm. Methods. 2000. — Vol.243. — P.59−75.
- Campana D., Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry // Cytometry. 1999. — Vol.38. — P. 139 152.
- Campbell G.T., Bhatnagar A.S. Simultaneous visualization by light microscopy of two pituitary hormones in a single tissue section using a combination of indirect immunohistochemical methods // J. Histochem. Cytochem. 1976. — Vol.24. — P.448−452.
- Cascavilla N., Musto P., D’Arena G., Ladogana S., Matera R., Carotenuto R. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression // Hematologica. -1997.-Vol.82.-P.31−37.
- Chen Z., Sandberg A.A. Molecular cytogenetic aspects of hematological malignancies: clinical implications // Am. J. Med. Genet. 2002. — Vol.115. -P.130−141.
- Cheson B.D., Bennett J.M., Rai K.R. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group // Am. J. Hematol. 1988. — Vol.29. -P.152−163.
- Coon W.W., Willis P.W., Keller J.B. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study // Circulation. 1973. — Vol.48. — P.839−846.
- Coons A.H., Creech H.J., Jones R.N. Immunological properties of an antibody containing a fluorescent group // Proc. Soc. Exp. Biol. Med. — 1941. Vol.47. — P.200−202.
- Corver W.E., Fleuren G.J., Cornelisse C.J. Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry // J. Immunol. Methods. 2002. -Vol.260. № 1−2.-P.97−107.
- Cualing H.D. Automated analysis in flow cytometry // Cytometry. -2000. Vol.42. № 2. — P.110−113.
- Dahmoush L., Hijazi Y., Barnes E., Stetler-Stevenson M., Abati A. Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flowcytometric study // Cancer. 2002. — Vol. 96. № 2. — P.110−116.
- Del Vecchio L., Brando B., Ortolani C., Pizzolo G., Semenzato G., Basso G. Recommended reporting format for flow cytometry diagnosis of acute leukemia // Haematologica. 2004. — Vol.89. № 5. — P.594−598.
- Delgado J., Morado M., Jimenez C.M., Garcia-Grande A., Hernandez-Navarrro F. CD56 expression in myelopeoxidase negative FAB M5 acute myeloid leukemia // Am. J. Hematol. 2002. — Vol.69. № 1. — P.28−30.
- Di Giuseppe J.A., Borowitz M.J. Clinical utility of flow cytometry in the chronic lymphoid leukemias // Semin. Oncol. 1998. — Vol.25. № 1. — P.6−10.
- Donnenberg A.D., Koch E.K., Griffin D.L., Stanczak H.M., Kiss J.E., Carlos T.M., Buchbarker D.M., Yeager A.M. Viability of cryopreserved bone marrow progenitor cells stored for more than a decade // Cytoterapy. -2002. Vol.4. № 2. — P.157−163.
- Dormandy J.A. Pathophysiology of venous leg ulceration: an update // Angiology.- 1997. Vol.48. — P.71−75.
- Dorshkind K. Multilineage development from adult bone marrow cells // Nature Immunology. 2002. — Vol.3. № 4. — P.311−313.
- Dowd P.M., Hudspith B.N., Miller J.A., Barr R.M., Brostoff J., Greaves M.W. Release in vivo of IL-1 like activity by human skin // Clin. Exp. Immunol. 1987. — Vol.67.№ 3. — P.606−610.
- Fagioli M., Alcalay M., Pandolfi P.P. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms // Oncogene. 1992. — Vol.7. — P.1083−1091.
- Ferrando A. and Look A.T. Gene expression profiling: will it complement or replace immunophenotyping? // Best Practice & Research Clinical Haematology. 2003. — Vol.16. № 4. — P.645−652.
- Foa R., Vitale A. Towards an integrated classification of adult acute lymphoblastic leukemia // Rev. Clin. Exp. Hematol. 2002. — Vol.6. -P.181−199.
- Foon K.A., Told R.F. Immunologic classification of leukemia and lymphoma // Blood. 1986. — Vol.68. № 1. — P. l-31.
- Fornas O., Garcia J., Retriz J. Flow cytometry of CD34+ cells in whole blood // Nature Med. 2000. — Vol.6. — P.833−836.k
- Franks P.J., Moffatt C.J., Connolly M. Community leg ulcer clinics: effect on quality of life // Phlebology. 1994. — Vol.9. — P.83−86.
- Gale R.P., Cozen P., Godman M., Wang F.F., Bernstein L. Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County // Leuk. Res. 2000. — Vol.24. — P.665−669.
- Gall E.A., Mallory T.B. Malignant lymphoma: a clinico-pathological survey of 618 cases // Amer. J. Pathol. 1942. — Vol.18. № 3. — P.381−429.
- Gallyas F., Gores T., Merchnthaler I. High-grade intensification of the end-product of the diaminobenzidine reaction for peroxidase histochemistry // J. Histochem. Cytochem. 1982. — Vol.30. № 2. — P.183−184.
- Galton D.A.G. The pathogenesis of chronic lymphocytic leukemia // Can. Med. Assoc. J. 1966. — Vol.94. — P.1005−1010.
- Garrido S.M., Willman C.L., Appelbaum F.R., Banker D.E. Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples // Cytometry (Comm.Clin. Cytometry). 2000. -Vol.42. — P.83−94.
- Gelman R., Wilkening C. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3+CD4+% // Cytometry (Comm in Clin Cytometry). 2000. — Vol.42. — P. l-4.
- Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation // Exp. Hematol. 2000. — Vol.28. — P. 1197−1205.
- Gluckman E., Broxmeyer H.A., Auerbach A.D. Hematopoietic reconstruction in a patient with Fanconi’s anemia by means of umbilical-cord blood from HLA-identical sibling // N. Engl. J. Med. 1989. -Vol.337.-P.373−381.
- Gotic M., Kraguljac N., Rolovic Z., Radosevic N., Boskovic D. Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia // Srp. Arh. Celok. Lek. 2000. — Vol.128. № 5−6. — P.157−164.
- Graham R.C., Lundholm U., Karnovsky M.J. Cytochemical demonstration of peroxidase activity with 3-amino-9-ethylcarbozole // J. Histochem. Cytochem. 1965. — Vol.13. — P.150−152.
- Greaves M. Molecular genetics, natural history and the demise of childhood leukemia // Eur. J. Cancer. 1999. — Vol.35. — P.1941−1953.
- Greaves M.F., Chan L.C., Farley A.J.W., Wan S.M., Molgaart H.V. Lineage promiscuity in hemopoietic differentiation and leukemia // Blood. -1986.-Vol.67.-P.l-11.
- Grogan W. McLean, Collins J.M. Guide to flow cytometry methods. / Marcel Dekker Inc, NY and Basel. 1990. — 227p.
- Hassett J., Parker J. Laboratory practices in reporting flow cytometry phenotyping results for leukemia/lymphoma specimens: results of survey // Cytometry. 1995. — Vol.22. — P.264−281.
- Hoelzer D., Gokbuget N., Ottman O., Pui C.-H., Relling M.V., Appelbaum F.R., van Dongen J.J.M., Szczepanski T. Acute lymphoblastic leukemia // Hematology. 2002. — Vol.1. — P.162−182.
- Hofman F. Immunohistochemistry. In: Current Protocols in Immunology. -1996. 5.8.1−5.8.2.3.
- Hrusak O., Porwit-McDonald A. Antigen expression patterns reflecting genotype of acute leukemias // Leukemia. 2002. — Vol.16. — P.1233−1258.
- Hsu S.-M., Raine L. / DeLellis R.A. (ed.) Advances in immunohistochemistry. NY: Masson. 1984.
- Hulkkonen J., Vilpo L., Hurme M., Vilpo J. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationship and effects of chromosomal abnormalities // Leukemia. 2002. — Vol.16. № 20. -P.178−185.
- Kay N.E., Hamblin T.J., Jelinck D.F., Dewald G.W., Byrd J.C., Farag S., Lucas M., Lin T. Chronic lymphocytic leukemia // Hematology. 2002. -Vol.1.-P.193−223.
- Keeney M, Brown W, Gratama J, Papa S, Lanza F, Sutherland DR- EuropeanWorking Group on Clinical Cell Analysis. Immunophenotypic characterization of CD34(pos) cells // J. Biol. Regul. Homeost. Agents. -2003. Vol.17. № 3. — P.254−260.
- Kern W, Schnittger S. Monitoring of acute myeloid leukemia by flow cytometry // Curr. Oncol. Rep. 2003. — Vol.5. № 5. — P.405−412.
- Killick S., Matute E., Powles R.L., Hamblin M., Swansbury J., Treleaven J.G., Zomas A., Atra A., Catovsky D. Outcome of biphenotypic acute leukemia // Hematologica. 1999. — Vol.84. № 8. — P.699−706.
- Kipps T.J. The CD5 B cell // Adv.Immunol. 1989. — Vol.47. — P.117−185.
- Knowles D.M. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia // Am. J. Pathol. 1989. -Vol.134. № 4.-P.761−785.
- Kohlmann A., Schoch C., Schnittger S., Dugas M., Hiddemann W., Kern W., Haferlach T. Molecular characterization of acute leukemias by use of microarray technology // Genes Chromosomes Cancer. 2003. — Vol.37. -P.396−405.
- Kuzel T.M., Roenigk H.H., Rosen S.T. Mycosis fungoides and the Sezary syndrome: a review of pathogenesis, diagnosis, and therapy // J. Clin. Oncol. -1991. Vol.9. № 7. — P.1298−1313.
- Lacombe F., Durrieu F., Briais A., Dumain P., Belloc F., Bascans E. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia // Leukemia. 1997. — Vol.11. — P.1878−1886.
- Lauer S, Piaskowski V, Camitta B, Casper J. Bone marrow and extramedullar variations of cell membrane antigen expressionin childhood lymphoid neoplasias at relapse // Leuk. Res. 1982. — Vol.6. № 6. — P.769−774.
- Lavabre-Bertrand T. Flow-cytometric quantitation in chronic leukemias // Eur. J. Histochem. 1996. — Vol.40. Suppl 1. — P.33−38.
- Lenkei R., Gratama J.W., Rothe G. Performance of calibration standards for antigen quantitation with flow cytometry // Cytometry. 1998. — Vol.33. — P.188−196.
- Linet M.S., Blatttner W.A. The epidemiology of CLL. In Chronic Lymphocytic Leukemia / A. Polliack and Catovsky D. (eds) Harwood Academic Publishers, Churc, Switzerland. 1988. — P. ll-32.
- Liu T.C. External quality assurance schemes in flow cytometry // Southeast Asian J. Trop. Med. Public Health. 2002. — Vol.33. Suppl. 2. -P.91−93.
- Lo Coco F., Nervi C., Avvisati G., Mandelli F. Acute promyelocytic leukemia: a curable disease // Leukemia. 1998. — Vol.12. — P.1866−1880.
- Lo-Coco F., Breccia M., Noguera N. Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemia // Best Practice & Research Clinical Haematology. 2003. — Vol.16. № 4. -P.653−670.
- Look A.T. Oncogenic transcription factors in the human acute leukemias // Science. 1997. — Vol.278. — P.1059−1064.
- Ludwig W.D., Raghavachar A., Thiel E. Immunophenotypic classification of acute lymphoblastic leukaemia // Baillieres Clin. Haematol. 1994. — Vol.7. № 2. — P.235−262.
- Luger T.A., Schwarz T., Krutmann J., Kock A., Urbanski A., Kirnbauer R. Cytokines and the skin // Curr. Probl. Dermatol. 1990. — Vol.19. — P.35−49.
- Lukes R.J., Collins R.D. New approaches to the classification of the lymphomas // Brit. J. Cancer. 1975. — Vol.31. Suppl.2. — P. l-28.
- Mandy F., Bergeron M., Minkus T. Evolution of leukocyte immunophenotyping as influenced by HIV/AIDS pandemic // Cytometry. -1997.-Vol.30.-P.157−165.
- Mason D.Y., Woolston R.-E. Double immunoenzymatic labeling. In Techniques in Immunohistochemistry /Eds. Bullock G.R., Petrusz P. London. Academic Press. 1982. — P.135−153.
- Matutes E., Catovsky D. The classification of lymphoid leukaemias // Leuk. Lymphoma. 1991. — Vol.5. Suppl. — P.153−155.
- Matutes E., Morilla R., Carbonell F., Swansbury J., Dyer M., Catovsky D. Defiition af acute biphenotypic leukemia // Hematologica. 1997. -Vol.82. — P.64−66.
- Matutes E., Pollack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia // Rev. Clin. Exp. Hematol. 2000. -Vol.4. №l.-P.22−46.
- McCoy J.P., Carey J.L., Krause J.R. Immunophenotyping and general laboratory procedures // Am. J. Clin. Pathol. 1990. — Vol.93. Supp.l. -P.S27-S37.
- McCoy J.P., Overton W.R. Quality control in flow cytometry for diagnostic pathology: II. A conspectus of reference ranges for lymphocyte immunophenotyping // Cytometry (Comm in Clin Cytometry). 1994. -Vol.18. -P.129−139.
- Medina K.L., Garrett K.P., Thompson L.F., Rossi M.I.D., Payne K.J., Kincade P.W. Identification of very early lymphoid precursor in bone marrow and their regulation // Nature Immunology. 2001. — Vol.2. № 8. -P.718−724.
- Montserrat E. Current therapy for CLL // Hematol. Cell Ther. 2000 -Vol.42. №l.-P.31−33.
- Moos P.J., Raetz E.A., Carlson M.A., Szabo A., Smith F.E., Willeman C. Identification of gene expression profiles that segregate patients with childhood leukemia // Clin. Cancer Res. 2002. — Vol.8. — P.3118−3130.
- Moreau E.J., Matutes E., A’Hern R.P. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b) // Am. J. Clin. Pathol. 1997. — Vol.108. — P.378−387.
- Naeim F. Selection of monoclonal antibodies in the diagnosis and classification of leukemias // Disease Markers. 1989. — Vol.7. — P. l-14.
- Nakane P.K., Pierce G.B. Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens // J. Cell Biol. 1967. -Vol.33. № 2.-P.307−318.
- Nemes Z. Intensification of 3'3-diaminobezidine precipitation using the ferric ferrocyanide reaction, and its application in te double-immuoperoxidase technique // Histochemistry. 1987. — Vol.86. — P.415−419.
- Nestle F.O., Haffner A.C., Schmid M.H., Dummer R., Burg G. Current therapy concepts in cutaneous T-cell lymphomas. // Schweiz. Med. Wochenschr. -1997. Bd. 127. № 8. — P.311−320. [German].
- Orfao A., Schmitz G., Brando B. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions // Clin. Chem. 1999. — Vol.45. -P.1708−1717.
- Owens M.A., Vail H.G., Hurley A.A., Wormsley S.B. Validation and quality control of immunophenotyping in clinical flow cytometry // J. Immunol. Methods. 2000. — Vol.243. № 1−2. — P.33−50.
- Paietta E. Comments on the 2001 WHO proposal for the classification of haematopoietic neoplasms // Best Practice & Research Clinical Haematology 2003. — vol.16. № 4. — P.547−559.
- Paietta E. How to optimize multiparameter flow cytometry for leukaemia/lymphoma diagnosis // Best Practice & Research Clinical Haematology. 2003. — Vol.16. № 4. — P.671−683.
- Partsch H. A new classification scheme of chronic venous disease in the lower extremities. The 'CEAP' system // Phlebolymphology. — 1995. -№ 10. -P.3−8.
- Porwit-MacDonald A., Bjorklund E., Lucio P., van Lochem E.C., Mazur I., Parreira A., van den Beemd M.W., van Wering E.R., Baars E., Gaipa G.,
- Powell C.C., Rohrer M.J., Barnard M.R., Peyton B.D., Furman M.I., Michelson A.D. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation // J. Vase. Surg. 1999. -Vol.30. № 5.-P.844−851.
- Pui C.H., Campana D., Evans W.E. Childhood acute lymphoblastic leukemia current status and future perspectives // Lancet Oncol. — 2001. -Vol.2. — P.597−607.
- Raghavachar A., Steinbach K.H., Prummer O., Grilli G., Fliedner T.M. Survival of transfused cryopreserved granulocytic progenitor cells (CFU-C) inrecipient circulation // Cell Tissue Kinet. 1983. — Vol.16. № 3. — P.303−311.
- Rai K.R., Sawitsky A., Cronkite E.P. Clinical staging of chronic lymphocytic leukemia // Blood. 1975. — Vol.46. -P.219−234.
- Ralfkiaer E. Controversies and discussion on early diagnosis of cutaneous T-cell lymphoma phenotyping // Dermatol. Clin. 1994. -Vol.12. № 2.-P.329−334.
- Rappaport H., Winter W.J., Hicks E.B. Follicular lymphoma: a reevaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases // Cancer. 1956. — Vol.9. № 1. — P.792−821.
- Ratei R., Sperling C., Karawajew L. Immunophentype and clinical characteristics on CD45-negative and CD45-positive childhood acute lymphoblastic leukemia // Ann. Hematol. 1998. -Vol.77. — P.107−114.
- Reading C.L., Estey E.H., Huh Y.O., Claxton D.F., Sanchez G., Terstappen L.W., O’Brien M.C., Baron S., Deisseroth A.B. Expression of unusual immunophenotype combinations in acute myelogenous leukemia // Blood. 1993. — Vol.81. — P.3083−3090.
- Reilly J.T., Barnett D. UK NEQAS for leukocyte immunophenotyping: the first 10 years // J. Clin. Pathol. 2001. — Vol.54. № 7. — P.508−511.
- Rezael A., Adib M., Mokarian F., teblanlan M., Nassiri R. Leukemia markers expression of peripheral blood vs. bone marrow using flow cytometry // Med Sci Monit. 2003. — Vol.9. № 8. — P. CR359−362.
- Richards S.J., Jack A.S. The development of integrated haemapathology laboratoties: a new approach to tpe diagnosis of leukemia and lymphoma // Clinical and Laboratory Haematology. 2003. — Vol.25. № 6. -P.:337−342.
- Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats // Cytometry. 2001. — Vol.45. № 3. -P.194−205.
- Rothe G., Schmitz G. European Working group on clinical cell analysis (EWGCCA) Consensus Document on Leukemia Immuniphenotyping // Leukemia. 1996. — Vol.10. — P.877−895.
- Ruiz A.A., Duque R.E., Orfao A. Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia // Cytometry. -1998. Vol. 34. — P.39−42.
- Schmid I., Ferbas J., Uittenbogaart CH., Giorgi JV. Flow cytometric analysis of live cell proliferation and phenotype in populations with low viability // Cytometry. 1999. — Vol.35. № 1. — P.64−74.
- Schmid I., Uittenbogaart C.H., Keld B., Giorgi J.V. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry // J. Immunol. Methods. 1994. — Vol.170. № 2. — P.145−157.
- Schmitz N., Barrett J. Optimizing engraftment source and dose of stem cells // Seminars in Hematology. — 2002. — Vol.39. № 1. — P.3−14.
- Schwartz A., Marti G.E., Poon R., Gratama J.W., Fernandez-Repollet E. Standartizing flow cytometry: a classification system of fluorescence standards used for flow cytomtery // Cytometry. 1998. — Vol.33. — P.106−114.
- Serke S., Johnsen H., Huhn D., Kvalheim G. European survey of the flow cytometric determination of CD34 expression cells // Cytotherapy. -1999.-Vol.1.-P.343−347.
- Serke S., Johnsen H.E. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts // Bone Marrow Transplant. 2001. — Vol27. № 5. — P.463−470.
- Shaffer A.L., Rosenwald A., Staudt L.M. Lymphoid malignancies: the dark side of B-cell differentiation // Nature Review Immunology. 2002. -Vol.2. — P.20−32.
- Shapiro H.M., Perlmutter N.G., Stein P.G. A flow cytometer designed for fluorescence calibration // Cytometry. 1998. — Vol.33. № 2. — P.280−287.
- Sims L.C., Brecher M.E., Gertis K., Jenkins A., Nickischer D., Schmitz JL., Sparks S., Wright P., Bentley S. Enumeration of CD34-positive stemcells evaluation and comparison of tree methods // J. Hematother. 1997. -Vol.6. — P.213−226.
- Slater D.N. Review of investigative diagnostic techniques for cutaneous lymphoma // Semin. Dermatol. 1994. — Vol.13. № 3. — P.166−171.
- Stelzer G.T., Shuts K.E., Loken M.R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens / In: Landay E. eds. Clinical flow cytometry. NewYork Ann of NY Acad Sci. — 1993. — P.265−280.
- Sternberg L.A. Immunocytochemistry. / 2nd ed., John Wiley and Sons.-New York.-1979.
- Stetler-Stevenson M. Flow cytometry in lymphoma diagnosis and prognosis: useful? // Best Practice & Research Clinical Haematology. -2003. Vol.16. № 4. — P.583−597.
- Stewart C.C., Stewart S.J. Immunological monitoring utilizing novel probes // NY Acad. Sci. 1993. — Vol.677. — P.94−112.
- Straus W. Imidazole increases the sensitivity of the cytochemical reaction for peroxidasewith diaminobenzidine at a neutral pH .// J. Histochem. Cytochem. 1982. — Vol.30. № 5. — P.491−493.
- Sulivan J.G., Wiggers T.B. Immunophenotyping of leukemia, the new force in hematology //Clin. Lab. Sci. 2000. — Vol.13. — P. l 17−122.
- Sutherland D. R, Anderson L., Keeney M., Nayar R., Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry // J. Hemother. 1996. — Vol.5. — P.213−226.
- Szczepanski T., van der Velden V.H.J., van Dongen J.J.M. Classification systems for acute and chronic leukemias // Best Practice & Research Clinical Haematology. 2003. — Vol.16. № 4. — P.561−582.
- Taylor C.G., Stasi R., Bastianelli C., Venditti A., Del Poeta G., Amadori S., Sargent J. Diagnosis and classification of the acute leukemias: recentadvances and controversial issues // Hematopathol. Mol. Hematol. 1996. -Vol.10. № 1−2.-P.l-38.
- Tenen D.G. Disruption of differentiation in human cancer: AML shows the way // Nature Review. 2003. — Vol.3. № 2. — P.89−101.
- Terstappen L.W.M., Mickaels R.A., Dost R., Loken M.R. Increased light scattering resolution facilitates multi-dimensional flow cytometric analysis // Cytometry. -1990. Vol.11. — P.506−512.
- Teshima T., Ferrara J.L.M. Understanding the alloresponse: new approaches to graft-versus-host disease prevention // Semin Hematology. -2002. Vol.39. № 1. — P.15−22.
- Thomas E.D. Bone marrow transplantation: past experiences and future prospects // Semin. Oncol. 1992. — Vol.19. № 3. Suppl.7. — P.3−6.
- Tytherleigh L., Taparia M., Leahy M.F. Detection of hairy cell leukemia in blood and bone marrow using multidimensional flow cytomery with CC45-PECY5 and SS gating // Clinical Laboratory Haematology. 2001. -Vol.23. № 6.-P. 385−390.
- Urasinski I, Zdziarska B. Indicators of nonspecific immunity in patients with non-Hodgkin's lymphoma of high grade malignancy in the remission phase of the disease. // Pol. Arch. Med. Wewn. 1991. — Vol.86. № 5. -P.304−310. [Polish]
- Verwer B.J., Terstappen L.W. Automatic lineage assignment of acute leukemias by flow cytometry // Cytometry. 1993. — Vol.14. — P.862−875.
- Vesely R., Barths J., Vanlangendonck F., Hannet I., Strauss K. Initial results of central immunophenotyping quality control program (CEQUAL) // Cytometry. -1996. Vol.26. № 2. — P.108−112.
- Vidriales M.B., San-Miguel J.F., Orfao A., Coustan-Smith E., Campana
- D. Minimal residual disease monitoring by flow cytometry // Best Practice & Research Clinical Haematology. 2003. — Vol. l6№ 4. — P.599−612.
- Waters W.R., Harkins K.R., Wannemuchler M.J. Five-color flow cytometric analysis of swine lymphocytes for detection of proliferation, apoptosis, viability, and phenotype // Cytometry. 2002. — Vol.48. № 3. -P.146−152.
- Weisburger E.K., Russfield A.B., Homburger F., Weisburger J.H., Boger
- E., van Dongen G.C. Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity // J. Environ. Pathol. Toxicol. 1978. — Vol.2. № 2. — P.325−356.
- Whiteside T.L., Gooding W. Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma // Blood Cells Mol. Dis. 2003. — Vol.31. № 1. — P.63−71.
- Wood G.S. Cutaneous lymphoproliferative disorders: strategies for molecular biological analysis and their major findings // Springer Semin. Immunopathol. 1992. — Vol.13. № 3−4. — P.387−399.
- Yeoh E.J., Ross M.E., Shurtleff S.A., Williams W.K., Patel D., Mahtouz R. Classification, subtype, discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling // Cancer Cell. -2002.-Vol.1. P.133−143.
- Zutter M.M., Hes J.L. Guidelines for the diagnosis of leukemia or lymphoma in children // Am. J. Clin. Pathol. 1998. — Vol.109. Suppl.l. -P.S9-S22.